Kindred Biosciences - 48 Year Dividend History | KIN

Historical dividend payout and yield for Kindred Biosciences (KIN) since 1971. The current TTM dividend payout for Kindred Biosciences (KIN) as of September 20, 2019 is $0.00. The current dividend yield for Kindred Biosciences as of September 20, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.301B $0.002B
Kindred Biosciences is a development-stage biopharmaceutical company focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company's strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for dogs, cats and horses. The Company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes.
Stock Name Country Market Cap PE Ratio